KH-CB19 ahydrate) It was originally developed as

It was originally developed as a potential treatment for pandemic influenza strains such as H5N1

decreases expression of cyclin D1 and the anti-apoptotic proteins Mcl-1 and XIAP

InChi: InChI=1S/C30H32O9/c1-16-12-18-13-21-25(38-15-37-21)26(35-5)22(18)23-19(14-20(33-3)24(34-4)27(23)36-6)28(30(16

5-bis(trifluoromethyl)phenyl)-1H-1

KH-CB19 ahydrate) It was originally developed asKH CB19 is a potent and selective inhibitor of CDC2 like kinase (CLK) 1 and 4. KH CB19 suppresses serine arginine rich protein phosphorylation by CLKs under proinflammatory conditions. Product information CAS Number: 1354037 26 5 Molecular Weight: 338. 19 Formula: C15H13Cl2N3O2 Chemical Name: ethyl 3 [(1E) 2 amino 1 cyanoeth 1 en 1 yl] 6,7 dichloro 1 methyl 1H indole 2 carboxylate Smiles: CCOC(=O)C1=C( C(=C\N) C#N)C2=CC=C(Cl)C(Cl)=C2N1C InChiKey: